Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
- Authors
- Lee, JY[Lee, Jung-Yun]; Park, J[Park, Junsik]; Lee, JK[Lee, Jae Kwan]; Jeong, DH[Jeong, Dae Hoon]; Kim, SI[Kim, Se Ik]; Choi, MC[Choi, Min Chul]; Kim, BG[Kim, Byoung-Gie]; Lim, MC[Lim, Myong Cheol]; Park, JY[Park, Jeong-Yeol]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.